ARTICLE SUMMARY:
We look back at the regulatory and reimbursement developments in 2022 that will impact medtech in 2023: what Europe’s new proposal to stretch out compliance deadlines for the MDR means for the device industry, key policy takeaways from December’s US Omnibus bill, and guidance from L.E.K. Consulting on achieving the “local” status so essential to breaking into China’s market.